Puma Biotechnology Inc (NASDAQ:PBYI) - Share price


Stock Report

Puma Biotechnology Inc PBYI

Last Price
$7.88

Day Change
0.44|5.91%

As of 06/12/2019
17:41:29 EST | USD
Minimum 15 Minutes Delay.

Last Close7.44
Day Range7.68 - 8.14
Mkt Cap307.00Mil
52-Wk Range6.26 - 43.90
Yield %-
ISINUS74587V1070
Volume2,394,317
P/E-11.01
P/S1.08
P/CF10.91

Share Price

Financials
201620172018
More ...
Income Statement
Revenue0.0027.69250.99
Operating Income-276.60-292.39-94.67
Net Income-276.01-291.96-113.58
Basic EPS-8.29-7.85-2.99
Avg. Diluted Shares Outstanding333738
Balance Sheet
Current Assets236.47106.39203.00
Non Current Assets16.3259.1356.12
Total Assets252.79165.53259.12
Current Liabilities37.4658.3467.12
Total Liabilities42.97112.22224.82
Total Equity209.8253.3034.31
Cash Flow
Operating Cash Flow-141.69-172.47-24.11
Capital Expenditure-7.28-50.43-0.61
Free Cash Flow-148.97-222.90-24.71

In millions, except "Basic EPS". Currency is USD.

Company Profile

Puma Biotechnology Inc is a biopharmaceutical company. It is engaged in the acquisition, development and commercialization of products to enhance cancer care. Its drug candidates are PB272 (neratinib, oral), PB272 (neratinib, intravenous), and PB357.

Sector

Healthcare

Industry

Biotechnology

Stock Style

Small-Value

Fiscal Year Ends

December

Employees

272
Key Stats
More ...
Price/Earning TTM-3.01
Price/Book16.87
Price/Sales TTM1.00
Rev Growth (3 year avg)-
EPS Growth (3 year avg)-
Operating Margin % TTM-37.72
Net Margin % TTM-45.25
ROE TTM-259.28
Debt/Equity4.43
Dividends
PreviousLatest
More ...
Declared Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2019 Morningstar. All rights reserved.